The “Microbial Metabolites and Chronic Pain” research axis explores the interactions between metabolites derived from the intestinal microbiota and the nervous system in the context of chronic pain. We are studying the role of the intestinal microbiota and its metabolites in the mechanisms of pain chronicization, in particular the involvement of the AhR/IL-22 pathway. We are also interested in the impact of microbial and/or tissue metabolites on the disturbances in “well-being” associated with chronic pain. Finally, we characterize new probiotics with anti-hyperalgesic potential, by evaluating their neuromodulatory power.
Journal articles
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2002
2001
Conference papers
2003
2002
2001
Book sections
2018
Habilitation à diriger des recherches
2023
Poster communications
2023
2022
2021
2019
Theses
2018
2011
Preprints, Working Papers, …
2021